Shanghai RAAS Blood Products Co Ltd Class A (002252) — Capital Reinvestment Ratio
Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Capital Reinvestment Ratio of 0.08x as of March 2025, meaning it reinvests 0% of its operating cash flow (CN¥775.56 Million) in capital expenditures (CN¥62.51 Million). Check how tangible is Shanghai RAAS Blood Products Co Ltd Clas's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai RAAS Blood Products Co Ltd Class A Capital Reinvestment Ratio (2005–2023)
This chart tracks Shanghai RAAS Blood Products Co Ltd Class A's Capital Reinvestment Ratio across 18 annual periods. For the full cash flow conversion analysis, see how efficiently does Shanghai RAAS Blood Products Co Ltd Clas generate cash.
Annual Capital Reinvestment Ratio for Shanghai RAAS Blood Products Co Ltd Class A (2005–2023)
Year-by-year Capital Reinvestment Ratio for Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2023. See Shanghai RAAS Blood Products Co Ltd Clas (002252) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.20x | CN¥2.28 Billion | CN¥450.80 Million | ▲ +51.3% |
| 2022 | 0.13x | CN¥1.73 Billion | CN¥225.73 Million | ▼ -17.3% |
| 2021 | 0.16x | CN¥1.29 Billion | CN¥204.61 Million | ▼ -26.6% |
| 2020 | 0.22x | CN¥1.17 Billion | CN¥251.76 Million | ▲ +21.4% |
| 2019 | 0.18x | CN¥872.69 Million | CN¥154.84 Million | ▼ -70.3% |
| 2018 | 0.60x | CN¥262.50 Million | CN¥156.94 Million | ▲ +1.8% |
| 2017 | 0.59x | CN¥268.76 Million | CN¥157.84 Million | ▲ +154.2% |
| 2016 | 0.23x | CN¥638.22 Million | CN¥147.49 Million | ▲ +21.2% |
| 2015 | 0.19x | CN¥762.42 Million | CN¥145.39 Million | ▲ +36.6% |
| 2014 | 0.14x | CN¥465.96 Million | CN¥65.06 Million | ▼ -75.4% |
| 2012 | 0.57x | CN¥263.46 Million | CN¥149.70 Million | ▼ -42.8% |
| 2011 | 0.99x | CN¥178.03 Million | CN¥176.80 Million | ▲ +122.9% |
| 2010 | 0.45x | CN¥200.21 Million | CN¥89.21 Million | ▼ -15.2% |
| 2009 | 0.53x | CN¥116.01 Million | CN¥60.99 Million | ▲ +93.6% |
| 2008 | 0.27x | CN¥107.64 Million | CN¥29.23 Million | ▲ +95.1% |
| 2007 | 0.14x | CN¥175.71 Million | CN¥24.46 Million | ▼ -38.3% |
| 2006 | 0.23x | CN¥53.58 Million | CN¥12.08 Million | ▼ -43.8% |
| 2005 | 0.40x | CN¥54.02 Million | CN¥21.69 Million | — |